Effective immediately, the updated US childhood vaccine schedule will reduce the number of recommended vaccines for all children to 11 diseases, down from 18. On January 5, 2026, the CDC updated the ...

Please check back later for more content.

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from December 2025. Another month has come and gone, and with it, several FDA approvals and regulatory ...

Strategic Alliance Partnership | Contemporary Pediatrics connects pediatricians with peer-reviewed articles, guideline updates, and practice strategies for real-world clinical application.

“We started out 2025 with an environment that was rife with myths and disinformation," said Robert H. Hopkins, Jr., MD, in this year-end recap of 2025 and the pediatric vaccine landscape. Pediatric ...

GeneDx’s ExomeDx and GenomeDx tests, now FDA Breakthrough Designated, offer comprehensive genomic analysis to improve diagnosis of rare and serious diseases. ExomeDx and GenomeDx tests provide ...

Daniela Carvalho, MD, explained how the FDA-approved Nexa cochlear implant system may reduce interruptions in hearing for children while reinforcing the need for infection prevention. The Nexa ...

A peer-to-peer discussion between Herbert Bravo, MD; and Marian Rewers, MD, PhD, examined immune-based treatments that preserved β-cell function and altered disease progression. In episode 5 of the ...

Abbott received FDA clearance for a new delivery system designed to simplify PDA closure in premature infants weighing as little as 2 lb. FDA clearance was granted for a delivery system designed ...

The FDA warns retailers over failure to remove recalled infant formula, urging stronger recall practices to protect infants and young children. The FDA has issued a reminder to the food industry ...

Phase 3 data show the Viaskin peanut patch improved desensitization vs placebo in children aged 4 to 7 years, supporting a planned FDA BLA in 2026. DBV Technologies announced positive top-line results ...